Pharmacy Usual Items - G20

  • G20
  • Revenue in the Pharmacy Usual Items market is projected to reach US$89.96bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.06%, resulting in a market volume of US$104.60bn by 2029.
  • In global comparison, most revenue will be generated in China (US$48,050.00m in 2024).
  • In relation to total population figures, per person revenues of US$25.41 are generated in 2024.

Key regions: Japan, France, China, Australia, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacy Usual Items market in G20 is experiencing significant growth and development.

Customer preferences:
Customers in the Pharmacy Usual Items market in G20 are increasingly seeking convenience and accessibility. With busy lifestyles and limited time, consumers are looking for quick and easy solutions for their healthcare needs. This has led to a rise in demand for over-the-counter medications, personal care products, and health supplements.

Trends in the market:
One of the key trends in the Pharmacy Usual Items market in G20 is the increasing focus on preventive healthcare. Consumers are becoming more proactive in managing their health and are willing to invest in products that can help prevent illnesses and maintain overall well-being. This has led to a growing demand for vitamins, dietary supplements, and herbal remedies. Another trend in the market is the growing popularity of online pharmacies. With the rise of e-commerce and digital platforms, consumers are now able to purchase their usual pharmacy items online, from the comfort of their own homes. This convenience factor, coupled with competitive pricing and a wide range of products, has contributed to the rapid growth of online pharmacies in the G20 countries.

Local special circumstances:
Each G20 country has its own unique set of circumstances that influence the development of the Pharmacy Usual Items market. For example, in countries with an aging population, there is a higher demand for products related to chronic disease management and elderly care. On the other hand, countries with a younger population may see a higher demand for products related to sports nutrition and general wellness. Furthermore, regulatory policies and healthcare systems also play a significant role in shaping the market. Some countries have stricter regulations on the sale of certain medications or require prescriptions for certain products, while others have more relaxed regulations. These differences in regulations can impact the availability and accessibility of pharmacy usual items in different G20 countries.

Underlying macroeconomic factors:
The growth of the Pharmacy Usual Items market in G20 is also influenced by underlying macroeconomic factors. Factors such as GDP growth, disposable income levels, and healthcare expenditure all contribute to the development of the market. As economies grow and consumers have more disposable income, they are more likely to spend on healthcare products and services, including pharmacy usual items. Additionally, the prevalence of chronic diseases and the overall health status of the population also impact the market. Countries with higher rates of chronic diseases may see a higher demand for medications and healthcare products, while countries with healthier populations may have a greater focus on preventive healthcare and wellness products. In conclusion, the Pharmacy Usual Items market in G20 is experiencing growth and development due to changing customer preferences, including the desire for convenience and preventive healthcare. The rise of online pharmacies and the influence of local special circumstances also contribute to the market trends. Underlying macroeconomic factors, such as GDP growth and healthcare expenditure, further shape the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)